Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00228293 · ClinicalTrials.gov registry record · Phase 2

Assessing CPR Quality During In-Hospital Cardiac Arrest

A Phase 2 study, sponsored by University of Chicago.

Terminated
Registry status
Phase 2
Development phase
200
Enrollment target

NCT00228293: Clinical Trial Phase 2 study, sponsored by University of Chicago.

NCT00228293 is a Phase 2 study that was terminated before completion, run by University of Chicago. The registered enrollment target is 200 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (50% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00228293, a Phase 2 study, was terminated before completion, sponsored by University of Chicago.

TERMINATED
Registry status
Phase 2
Development phase
200 participants
Enrollment target

Study Summary

Using an investigational monitor/defibrillator that passively records CPR quality parameters, including chest compression rate and depth and ventilation rate and volume, we are prospectively recording CPR quality during sequential in-hospital cardiac arrests at the University of Chicago Hospitals. Using an audio feedback system linked to this device, we are studying whether such audio feedback improves CPR quality when provided to rescuers trained in the use of the device.

Interventions

  • DEVICE investigational monitor/defibrillator with CPR feedback

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2002-12
Est. Completion 2005-09
Phase Phase 2
University of Chicago

796 total trials

Why NCT00228293 stopped before completion

NCT00228293 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (50% higher).

The record links to 0 conditions, and to 1 intervention - of which investigational monitor/defibrillator with CPR feedback is the first listed.

NCT00228293 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00228293 about?

NCT00228293 is a clinical study titled "Assessing CPR Quality During In-Hospital Cardiac Arrest". Using an investigational monitor/defibrillator that passively records CPR quality parameters, including chest compression rate and depth and ventilation rate and volume, we are prospectively recording CPR quality during sequential in-hospital cardiac arrests at the University of Chicago Hospitals. U...

What is the current status of trial NCT00228293?

This trial is currently terminated. It is a Phase 2 study. The enrollment target is 200 participants. The study started on 2002-12. Estimated completion is 2005-09.

What interventions are being tested in trial NCT00228293?

The interventions under investigation include: investigational monitor/defibrillator with CPR feedback (DEVICE).

Who is sponsoring clinical trial NCT00228293?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00228293's enrollment target sits among peer trials

200 304th of 2000 higher than 1,652 of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00228293, the US trial registry maintained by the National Library of Medicine. NCT00228293 (mid enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.